Prospective Evaluation of Strontium in Patients After CardioGen-82 PET MPI Scanning at Two Clinical Sites

Completed

Conditions studied: Radiation Exposure

In brief

This study is to be performed at two clinical sites where patients received CardioGen-82 during the time period January to June, 2011 and where patients were scanned chronologically near to the index patients (2 days before or after). Of these, it is planned that at least 30 patients will be entered in this trial. Index patient is the term applied to individuals who had radiation spectra indicative of Sr-82 and Sr-85 detected by hand-held survey meters.

Key facts

Study ID

NCT01430975

Run by

Bracco Diagnostics, Inc

People needed

72

Starts

2011-09-01

Expected to finish

2012-03-01

Last updated by the study team

2012-04-25

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female;
• Gave informed consent to participate in the study;
• Received CardioGen-82 that has been eluted from the generator in close proximity (2 days before or after) the index patients.

You may not qualify if…

• Any patient previously enrolled in and completed this study.

Where it is running

• Bracco Diagnostics, Inc. — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.